• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Pediatric Infect Dis Soc . SARS-CoV-2 Screening Testing Program for Safe In-person Learning in K-12 Schools

tetano

Editor, Senior Moderator
J Pediatric Infect Dis Soc


. 2022 Nov 22;piac119.
doi: 10.1093/jpids/piac119. Online ahead of print.
SARS-CoV-2 Screening Testing Program for Safe In-person Learning in K-12 Schools


Ibukunoluwa C Kalu[SUP] 1 2 [/SUP], Kanecia O Zimmerman[SUP] 1 2 3 [/SUP], Jennifer L Goldman[SUP] 4 [/SUP], Dana Keener Mast[SUP] 5 [/SUP], Ashley M Blakemore[SUP] 1 [/SUP], Ganga Moorthy[SUP] 1 2 [/SUP], Angelique E Boutzoukas[SUP] 1 2 [/SUP], Melissa M Campbell[SUP] 1 2 [/SUP], Diya Uthappa[SUP] 6 [/SUP], Jesse DeLaRosa[SUP] 1 [/SUP], Jessica M Potts[SUP] 5 [/SUP], Laura J Edwards[SUP] 1 [/SUP], Rangaraj Selvarangan[SUP] 4 [/SUP], Daniel K Benjamin[SUP] 1 2 3 [/SUP], Tara K Mann[SUP] 1 [/SUP], Jennifer E Schuster[SUP] 4 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening testing is a recommended mitigation strategy for schools, although few descriptions of program implementation are available.
Methods: Kindergarten through 12th grade (K-12) students and staff practicing universal masking during the delta and omicron variant waves from 5 schools in Durham, North Carolina and 8 in Kansas City, Missouri participated; Durham's program was structured as a public health initiative facilitated by school staff, and Kansas City's as a research study facilitated by a research team. Tests included school-based rapid antigen or polymerase chain reaction testing, at-home rapid antigen testing, and off-site nucleic acid amplification testing.
Results: We performed nearly 5,700 screening tests on more than 1,600 K-12 school students and staff members. The total cost for the Durham testing program in 5 public charter K-12 schools, each with 500-1000 students, was $246,587 and approximately 752 hours per semester; cost per test was $70 and cost per positive result was $7,076. The total cost for the Kansas City program in 8 public K-12 schools was $292,591 and required approximately 537 hours in personnel time for school-based testing; cost per test was $132 and cost per positive result was $4,818. SARS-CoV-2 positivity rates were generally lower (0-16.16%) than rates in the community (2.7-36.47%) throughout all testing weeks.
Conclusions and relevance: Voluntary screening testing programs in K-12 schools are costly and rarely detect asymptomatic positive persons, particularly in universally masked settings.

Keywords: K–12 school communities; SARS-CoV-2; screening testing.
 
Back
Top Bottom